Pieris Pharmaceuticals Inc buy BiotechBee
Start price
02.01.23
/
60%
€1.04
Target price
31.12.25
€3.00
Performance (%)
-26.41%
End price
05.05.23
€0.77
Summary
This prediction ended on 05.05.23 with a price of €0.77. The price of Pieris Pharmaceuticals Inc has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -26.41%. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Pieris Pharmaceuticals Inc | - | - | - |
| iShares Core DAX® | 0.795% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -3.088% | -0.762% | 3.169% |
| iShares Nikkei 225® | -0.952% | -2.268% | 12.208% |
| iShares S&P 500 | -1.393% | 0.199% | 1.698% |
According to BiotechBee what are the pros and cons of Pieris Pharmaceuticals Inc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Pieris Pharmaceuticals Inc diskutieren
Buy mit Kursziel 3,0
In the thread Trading Pieris Pharmaceuticals Inc
Buy beendet

